1-5 of 5
tocilizumab
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial

Clinical Trials & Observations
Stephen J. Schuster, Richard T. Maziarz, Elisha S. Rusch, Junlong Li, James E. Signorovitch, Vadim V. Romanov, Frederick L. Locke, David G. Maloney
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1432–1439.
https://doi.org/10.1182/bloodadvances.2019001304
Published: 2020
Includes: Supplemental data
Journal Articles

First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab

Clinical Trials & Observations Global Advances
Xuhan Zhang, Kaidi Song, Fei Tong, Mingming Fei, Hui Guo, Zhaohui Lu, Jinquan Wang, Changcheng Zheng
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1307–1310.
https://doi.org/10.1182/bloodadvances.2020001907
Published: 2020
Journal Articles

Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management

Clinical Trials & Observations
Martina Pennisi, Tania Jain, Bianca D. Santomasso, Elena Mead, Kitsada Wudhikarn, Mari Lynne Silverberg, Yakup Batlevi, Roni Shouval, Sean M. Devlin, Connie Batlevi, Renier J. Brentjens, Parastoo B. Dahi, Claudia Diamonte, Sergio Giralt, Elizabeth F. Halton, Molly Maloy, Maria Lia Palomba, Miriam Sanchez-Escamilla, Craig S. Sauter, Michael Scordo, Gunjan Shah, Jae H. Park, Miguel-Angel Perales
Journal: Blood Advances
Blood Adv (2020) 4 (4): 676–686.
https://doi.org/10.1182/bloodadvances.2019000952
Published: 2020
Journal Articles

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia

Clinical Trials & Observations
Sarah Cooley, Fiona He, Veronika Bachanova, Gregory M. Vercellotti, Todd E. DeFor, Julie M. Curtsinger, Paul Robertson, Bartosz Grzywacz, Kevin C. Conlon, Thomas A. Waldmann, David H. McKenna, Bruce R. Blazar, Daniel J. Weisdorf, Jeffrey S. Miller
Journal: Blood Advances
Blood Adv (2019) 3 (13): 1970–1980.
https://doi.org/10.1182/bloodadvances.2018028332
Published: 2019
Includes: Supplemental data
Journal Articles

No free rides: management of toxicities of novel immunotherapies in ALL, including financial

Clinical Trials & Observations
Tania Jain, Mark R. Litzow
Journal: Blood Advances
Blood Adv (2018) 2 (22): 3393–3403.
https://doi.org/10.1182/bloodadvances.2018020198
Published: 2018